⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28936676 | 0.97 | ALDH1A1 (0.34) | — | |
| SCHEMBL5176797 | 0.73 | ALDH1A1 (0.38) | — | |
| SCHEMBL98364 | 0.73 | — | — | |
| SCHEMBL10066918 | 0.73 | — | — | |
| SCHEMBL30272404 | 0.71 | ALDH1A1 (0.32) | — | |
| Bromide SCHEMBL17335765 | 0.71 | ALDH1A1 (0.36) | — | |
| Iodide SCHEMBL4435737 | 0.71 | ALDH1A1 (0.32) | — | |
| Hydrochloric Acid SCHEMBL3908734 | 0.71 | ALDH1A1 (0.32) | — | |
| SCHEMBL266061 | 0.69 | — | — | |
| SCHEMBL5455473 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107630385-B | Microfibrous cellulose aggregate, process for producing same, and process for remanufacturing microfibrous cellulose dispersion | 王子控股株式会社 | 2020-12-11 | — | — | CN | disclosed |
| CN-110062771-A | Polymer, resin composition, antifouling coating composition, method for producing polymer, method for forming structure for stabilizing urethane on coating film surface, and method for regenerating structure for stabilizing urethane on coating film surface | 学校法人早稻田大学 | 2019-07-26 | — | — | CN | disclosed |
| EP-2346528-B1 | NICOTINE IMMUNONANOTHERAPEUTICS | MASSACHUSETTS INST TECHNOLOGY (US) | 2016-04-06 | — | — | EP | disclosed |
| US-8932595-B2 | Nicotine immunonanotherapeutics | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-01-13 | — | — | US | disclosed |
| US-8591905-B2 | Nicotine immunonanotherapeutics | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2013-11-26 | — | — | US | disclosed |
| CN-103298861-A | Process for production of finely fibrous cellulose composite prepreg sheet, process for production of finely fibrous cellulose composite sheet, and process for production of finely fibrous cellulose composite laminate sheet | OJI HOLDINGS CORP | 2013-09-11 | — | — | CN | disclosed |
| US-20130142821-A1 | Hapten-Carrier Conjugates and Uses Thereof | CYTOS BIOTECHNOLOGY AG (CH) | 2013-06-06 | — | — | US | disclosed |
| US-8187607-B2 | Hapten-carrier conjugates and uses thereof | CYTOS BIOTECHNOLOGY AG (CH) | 2012-05-29 | — | — | US | disclosed |
| US-20120027808-A1 | NICOTINE IMMUNONANOTHERAPEUTICS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2012-02-02 | — | — | US | disclosed |
| EP-2392345-A2 | Hapten-carrier conjugates comprising virus like particles and uses thereof | Cytos Biotechnology AG (CH) | 2011-12-07 | — | — | EP | disclosed |
| US-20080255152-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY | 2008-10-16 | — | — | US | disclosed |
| US-7381719-B2 | Diaryl ethers as opioid receptor antagonist | ELI LILLY AND COMPANY (US) | 2008-06-03 | — | — | US | disclosed |
| US-20060217372-A1 | Diaryl ethers as opioid receptor antagonist | ELI LILLY AND COMPANY | 2006-09-28 | — | — | US | disclosed |
| US-20050281845-A1 | Hapten-carrier conjugates and uses thereof | CYTOS BIOTECHNOLOGY AG (CH) | 2005-12-22 | — | — | US | disclosed |
| US-6932971-B2 | Hapten-carrier conjugates and uses thereof | CYTOS BIOTECHNOLOGY AG (CH) | 2005-08-23 | — | — | US | disclosed |
| EP-1562595-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2005-08-17 | — | — | EP | disclosed |
| EP-1523334-A2 | HAPTEN-CARRIER CONJUGATES AND USES THEREOF | Cytos Biotechnology AG (CH) | 2005-04-20 | — | — | EP | disclosed |
| WO-2004026305-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONIST | ELI LILLY AND COMPANY (US) | 2004-04-01 | — | — | WO | disclosed |
| US-20040059094-A1 | Hapten-carrier conjugates and uses thereof | CYTOS BIOTECHNOLOGY AG (CH) | 2004-03-25 | — | — | US | disclosed |
| WO-2004009116-A2 | HAPTEN-CARRIER CONJUGATES COMPRISING VIRUS LIKE PARTICLES AND USES THEREOF | CYTOS BIOTECHNOLOGY AG (CH) | 2004-01-29 | — | — | WO | disclosed |